These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2465792)

  • 21. The contact-system dependent plasminogen activator from human plasma: identification and characterization.
    Binnema DJ; Dooijewaard G; van Iersel JJ; Turion PN; Kluft C
    Thromb Haemost; 1990 Nov; 64(3):390-7. PubMed ID: 2128968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of low- and high-molecular-weight plasminogen activators on the onset of labor and on the hemostatic system.
    Moriyama T; Suzuki S; Matsuno K; Okada K; Matsuo O
    Semin Thromb Hemost; 2002 Dec; 28(6):529-32. PubMed ID: 12536345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contact activation of prekallikrein and of fibrinolysis by heparinoids and heparin.
    Soulier JP; Gozin D
    Haematologia (Budap); 1980; 13(1-4):117-28. PubMed ID: 6166520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the fibrinolytic system in human plasma: quantitative determination of plasminogen activators and proactivators.
    Kluft C
    Thromb Haemost; 1979 Apr; 41(2):365-83. PubMed ID: 473118
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system.
    Berrettini M; Schleef RR; España F; Loskutoff DJ; Griffin JH
    J Biol Chem; 1989 Jul; 264(20):11738-43. PubMed ID: 2787318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of fibrinolytic activity in bovine plasma by the combined effects of chloroform and dextran sulphate.
    Jenks RL; Kluft C; Astrup T
    Haemostasis; 1981; 10(2):108-18. PubMed ID: 6161866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E.
    Hojima Y; Cochrane CG; Wiggins RC; Austen KF; Stevens RL
    Blood; 1984 Jun; 63(6):1453-9. PubMed ID: 6202346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of prekallikrein activation in human plasma by components of bovine plasma.
    Weerasinghe KM; Kirby EP
    Inflammation; 1992 Oct; 16(5):497-507. PubMed ID: 1428124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
    Joseph K; Tholanikunnel BG; Kaplan AP
    J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays.
    Nuijens JH; Huijbregts CC; Cohen M; Navis GO; de Vries A; Eerenberg AJ; Bakker JC; Hack CE
    Thromb Haemost; 1987 Aug; 58(2):778-85. PubMed ID: 2445044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA.
    Stalder M; Hauert J; Kruithof EK; Bachmann F
    Br J Haematol; 1985 Sep; 61(1):169-76. PubMed ID: 4052324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
    Loza JP; Gurewich V; Johnstone M; Pannell R
    Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contact activation of prekallikrein and plasminogen in plasma].
    Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
    Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
    Wiggins RC
    Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill.
    Campbell SJ; Mackie IJ; Robinson GE; Machin SJ
    Br J Obstet Gynaecol; 1993 Jan; 100(1):79-84. PubMed ID: 8427844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.